Inventor

HEITSCH HOLGER

DE36 patents

⚠️ This page may combine multiple inventors who share the name “HEITSCH HOLGER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HEITSCH HOLGER

AVENTIS PHARMA GMBH

Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them

1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them

Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists

1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them

P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use

P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use

Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart

Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels

Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them

Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers

2,5-substituted benzolsulfonylureas and thioureas methods for the production thereof use thereof and pharmaceutical preparations containing the same

Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer&#39;s disease

Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use, and pharmaceutical preparations comprising them

HOECHST AG

Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Benzimidazole derivatives as angiotensin II receptor antagonists, pharmacticals, and treatment of hypertension therewith

Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain and their use as angitensin II receptors

Imidazopyridine derivatives as angiotensin II receptor antagonists, pharmaceuticals, and treatment of hypertension therewith

Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Angiotensin II receptor antagonists for the treatment of disturbances in cardiac rhythm

Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use

Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease

Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease

Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor antagonists

Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use

Amino acid derivatives with renin-inhibiting properties, a process for the preparation thereof, agents containing these, and the use thereof

HACHTEL STEPHANIE

CXCR2 inhibitors

Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them

CXCR2 inhibitors

SANOFI AVENTIS DEUTSCHLAND

CXCR2 inhibitors

Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels

AIRBUS OPERATIONS GMBH

Network for an aircraft or spacecraft, an aircraft or spacecraft, and a method for configuring a network

Network for an aircraft or spacecraft, and an aircraft or spacecraft including such network

HOECHST MARION ROUSSEL DE GMBH

Use of non-peptide bradykinin antagonists for the treatment or prevention of Alzheimer&#39;s disease

ROUSSEL UCLAF

Process for the preparation of 1-[(1,1&#39;-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids

KALLUS CHRISTOPHER

Imidazole derivatives used as TAFIa inhibitors

SANOFI AVENTIS

Imidazole derivatives as inhibitors of TAFIa

Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease

Use of non-peptide bradykinin antagonists for the treatment or prevention of Alzheimer's disease

Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids